We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.1%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$5.88B
AUM Growth
+$1.01B
Cap. Flow
+$924M
Cap. Flow %
15.72%
Top 10 Hldgs %
9.87%
Holding
605
New
228
Increased
122
Reduced
115
Closed
133

Sector Composition

Rank Sector Weight
1 Healthcare 14.61%
2 Financials 12.78%
3 Industrials 11.19%
4 Technology 9.23%
5 Consumer Discretionary 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCF
351
DELISTED
TCF Financial Corporation
TCF
$1.76M 0.03%
+110,675
New +$1.7M
SAGE
352
DELISTED
Sage Therapeutics
SAGE
$1.74M 0.03%
47,515
-52,159
-52% -$1.94M
HRTX icon
353
Heron Therapeutics
HRTX
$92.9M
$1.73M 0.03%
171,554
+45,885
+37% +$374K
TSRO
354
DELISTED
TESARO, Inc.
TSRO
$1.68M 0.03%
45,228
-17,722
-28% -$547K
CVS icon
355
CVS Health
CVS
$122B
$1.67M 0.03%
+17,311
New +$1.53M
CNXR
356
DELISTED
Connecture, Inc.
CNXR
$1.58M 0.03%
+175,000
New +$1.57M
HPTX
357
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.56M 0.03%
+65,000
New +$1.47M
RLYP
358
DELISTED
RELYPSA INC COM
RLYP
$1.5M 0.03%
+48,697
New +$1.16M
WPM icon
359
Wheaton Precious Metals
WPM
$60.9B
$1.47M 0.03%
+72,322
New +$1.44M
DVN icon
360
Devon Energy
DVN
$47.3B
$1.46M 0.02%
23,868
-468,946
-95% -$28.4M
MS icon
361
Morgan Stanley
MS
$340B
$1.46M 0.02%
+37,569
New +$1.34M
OXY icon
362
Occidental Petroleum
OXY
$55.9B
$1.46M 0.02%
18,120
-396,583
-96% -$32.9M
NDAQ icon
363
Nasdaq
NDAQ
$52.9B
$1.45M 0.02%
+90,384
New +$1.33M
PETX
364
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.45M 0.02%
81,104
-24,396
-23% -$304K
BA icon
365
Boeing
BA
$185B
$1.43M 0.02%
+10,997
New +$1.39M
SWK icon
366
Stanley Black & Decker
SWK
$15.7B
$1.42M 0.02%
+14,761
New +$1.36M
WBC
367
DELISTED
WABCO HOLDINGS INC.
WBC
$1.39M 0.02%
+13,268
New +$1.31M
WPRT
368
Westport Fuel Systems
WPRT
$35.7M
$1.37M 0.02%
+36,733
New +$1.93M
DHR icon
369
Danaher
DHR
$144B
$1.37M 0.02%
+23,715
New +$1.29M
MVNR
370
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
$1.36M 0.02%
100,000
-78,016
-44% -$949K
KND
371
DELISTED
Kindred Healthcare
KND
$1.35M 0.02%
+74,437
New +$1.47M
AMPH icon
372
Amphastar Pharmaceuticals
AMPH
$916M
$1.35M 0.02%
116,188
+17,214
+17% +$187K
PRQR icon
373
ProQR Therapeutics
PRQR
$265M
$1.32M 0.02%
61,115
-74,115
-55% -$1.12M
GTT
374
DELISTED
GTT Communications, Inc.
GTT
$1.32M 0.02%
+100,000
New +$1.28M
FOMX
375
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.31M 0.02%
186,289
+3,680
+2% +$21.1K

Similar funds

Alyeska Investment Group's Q4 2014 Portfolio in Review

As of Q4 2014, Alyeska Investment Group held 605 positions worth $5.88B, up 21% from $4.86B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Alyeska Investment Group deployed $924M of net new capital in Q4 2014, opening 228 new positions and adding to 122 existing holdings. Its largest new stake was Halliburton: 1,234,449 shares worth $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Bloomin' Brands, an estimated $42.5M trimmed.

  • Alyeska Investment Group's largest Q4 2014 buy was Halliburton: 1,234,449 shares worth $48.6M.
  • Alyeska Investment Group added most to HD Supply Holdings, Inc. in Q4 2014, an estimated $50.6M increase.
  • Alyeska Investment Group's biggest Q4 2014 reduction was Bloomin' Brands, cutting an estimated $42.5M.
  • Alyeska Investment Group fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $61.6M.
  • Alyeska Investment Group's ten largest holdings make up 9.9% of its $5.88B portfolio in Q4 2014.
  • Alyeska Investment Group opened 228 new positions and closed 133 in Q4 2014.
  • Alyeska Investment Group's portfolio value rose 21% quarter-over-quarter to $5.88B.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.